No abstract available
MeSH terms
-
Adult
-
Age Factors
-
Antimetabolites, Antineoplastic / administration & dosage
-
Antimetabolites, Antineoplastic / therapeutic use
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Agents, Hormonal / administration & dosage
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / radiotherapy
-
Breast Neoplasms / surgery
-
Chemotherapy, Adjuvant
-
Cisplatin / therapeutic use
-
Combined Modality Therapy
-
Female
-
Fluorouracil / administration & dosage
-
Fluorouracil / therapeutic use
-
Goserelin / administration & dosage
-
Goserelin / therapeutic use
-
Humans
-
Lymph Node Excision
-
Lymphatic Metastasis
-
Mastectomy
-
Methotrexate / therapeutic use
-
Middle Aged
-
Neoplasm Recurrence, Local
-
Ovariectomy
-
Postoperative Care
-
Preoperative Care
-
Prognosis
-
Risk Factors
-
Tamoxifen / administration & dosage
-
Tamoxifen / therapeutic use
Substances
-
Antimetabolites, Antineoplastic
-
Antineoplastic Agents
-
Antineoplastic Agents, Hormonal
-
Tamoxifen
-
Goserelin
-
Cisplatin
-
Fluorouracil
-
Methotrexate